Cargando…
Rationale for Nicotinamide Adenine Dinucleotide (NAD+) Metabolome Disruption as a Pathogenic Mechanism of Post-Acute COVID-19 Syndrome
Many acute COVID-19 convalescents experience a persistent sequelae of infection, called post-acute COVID-19 syndrome (PACS). With incidence ranging between 31% and 69%, PACS is becoming increasingly acknowledged as a new disease state in the context of SARS-CoV-2 infection. As SARS-CoV-2 infection c...
Autores principales: | Block, Tabitha, Kuo, Jonathann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234841/ https://www.ncbi.nlm.nih.gov/pubmed/35769168 http://dx.doi.org/10.1177/2632010X221106986 |
Ejemplares similares
-
Metabolism and biochemical properties of nicotinamide adenine dinucleotide (NAD) analogs, nicotinamide guanine dinucleotide (NGD) and nicotinamide hypoxanthine dinucleotide (NHD)
por: Yaku, Keisuke, et al.
Publicado: (2019) -
Nicotinamide Adenine Dinucleotide (NAD) Metabolism as a Relevant Target in Cancer
por: Navas, Lola E., et al.
Publicado: (2022) -
Potential of nicotinamide adenine dinucleotide (NAD) for management of root-knot nematode in tomato
por: Regmi, Homan, et al.
Publicado: (2021) -
Nicotinamide adenine dinucleotide as a photocatalyst
por: Kim, Jinhyun, et al.
Publicado: (2019) -
Impaired nicotinamide adenine dinucleotide (NAD(+)) metabolism in diabetes and diabetic tissues: Implications for nicotinamide‐related compound treatment
por: Fan, Lan, et al.
Publicado: (2020)